XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$154.87
-7.00 (-4.32%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$161.99
Prev Close$161.87
Day Range$154.44 — $162.68
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
17.2%
From 52W Low
+132.3%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $154.87 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,911.68
Annual Income$9.91
Monthly Income$0.83
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $265.08 | -0.05% | 466.74B |
| AMGN | $406.09 | -1.01% | 207.25B |
| GILD | $151.37 | -0.85% | 187.10B |
| VRTX | $516.34 | +0.26% | 130.64B |
| REGN | $801.82 | -0.26% | 80.58B |
| MRNA | $182.11 | -0.25% | 63.11B |
| NTRA | $390.79 | -0.03% | 52.80B |
| RVMD | $190.74 | -1.10% | 42.21B |
| BIIB | $227.53 | +0.96% | 32.37B |
| ALNY | $246.51 | -2.04% | 32.33B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Sep 23, 2026 at 6:15 PM ET